Thus, it is difficult to distinguish between interstitial fibrosis and residual cancer caused by NAT, and the sensitivity and specificity of pCR prediction for breast cancer are 60.8% and 78%, respectively [28]. The gene discussed is BRD2; the disease is cancer.